滚动资讯
FierceBiotechLabcorp launches rapid fentanyl test with 48-hour detection windowFierceBiotechWas Big Pharma’s ‘unusually aggressive’ M&A spree to blame for March IPO drought?FierceBiotechSpain sets up Boston-focused VC fund with goal of raising $200M for biotechsFierceBiotechNovartis CEO Vas Narasimhan joins Anthropic’s board as biopharma’s ties to AI deepenEndpoints NewsIn vivo CAR-T race for autoimmune grows as two RNA startups enter the clinicLonza NewsLonza Singapore Lab: Media Development for Bioprocessing Scale-Up | 2026 - News and Statistics - IndexBoxEndpoints NewsBiogen filing reveals Apellis deal details; Telix raises $600MAgilentAgilent (A) Showcases Innovations at AACR 2026 Annual Meeting - GuruFocusEndpoints NewsFormer FDA cancer chief Pazdur warns of the political 'breach' of review teamsEndpoints NewsTampa General's AI journeyEndpoints NewsRevolution Medicines prices $2B raise as XBI reaches heights not seen since pandemicBioPharma DiveObsidian, Galera to advance cell therapy following reverse merger
FierceBiotech 2026年4月15日

Novartis CEO Vas Narasimhan joins Anthropic’s board as biopharma’s ties to AI deepen

Novartis CEO Vas Narasimhan joins Anthropic’s board as biopharma’s ties to AI deepen

暂时没有全文,请查看原始来源。

目录

1122 全部